Key points are not available for this paper at this time.
Electrocatalytic CO2 reduction by heterogeneous molecular catalysts is emerging as an important area for CO2 utilization.
Sun et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: